This inventor holds 4 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignee: Yale University. Active years: 2020-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Hamden, CT (US) (2022)
- New Haven, CT (US) (2020 - 2024)
Company Filing History:
Years Active: 2020-2024
Title: Innovations and Contributions of Rachel Jamison Perry
Introduction
Rachel Jamison Perry is a prominent inventor based in New Haven, CT (US). She has made significant contributions to the field of biomedical research, particularly in the area of mitochondrial metabolism and its implications for various diseases. With a total of 4 patents, her work has garnered attention for its potential therapeutic applications.
Latest Patents
Among her latest patents, two stand out for their innovative approaches. The first patent, titled "2,4-dinitrophenol formulations and methods using same," presents a low dose and sustained release formulation of a mitochondrial uncoupling agent. This composition is designed to prevent or treat diseases such as non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, insulin resistance, and diabetes. The second patent, "Non-invasive assessment of hepatic mitochondrial metabolism by positional isotopomer NMR tracer analysis (PINTA)," introduces a method to non-invasively assess rates of hepatic mitochondrial oxidation and pyruvate carboxylase flux. This method utilizes a combined NMR/gas chromatography-mass spectrometry analysis of plasma, providing a valuable tool for investigating altered hepatic mitochondrial metabolism and the effects of therapeutic interventions.
Career Highlights
Rachel is affiliated with Yale University, where she conducts her research and develops her innovative solutions. Her work has not only advanced scientific understanding but also opened new avenues for treatment options in metabolic diseases.
Collaborations
Throughout her career, Rachel has collaborated with esteemed colleagues, including Gerald I Shulman and Gary Cline. These partnerships have enhanced her research and contributed to the success of her innovative projects.
Conclusion
Rachel Jamison Perry's contributions to the field of biomedical research exemplify the impact of innovation on healthcare. Her patents reflect a commitment to addressing critical health issues through scientific advancement.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile